Literature DB >> 29722002

Genetics of metastasis: melanoma and other cancers.

Noel Turner1, Olivia Ware2, Marcus Bosenberg3,4,5,6.   

Abstract

Melanoma is a malignant neoplasm of melanocytes that accounts for the majority of skin cancer deaths despite comprising less than 5% of all cutaneous malignancies. Its incidence has increased faster than that of any other cancer over the past half-century and the annual costs of treatment in the United States alone have risen rapidly. Although the majority of primary melanomas are cured with local excision, metastatic melanoma historically carries a grim prognosis, with a median survival of 9 months and a long-term survival rate of 10%. Given the urgent need to develop treatment strategies for metastatic melanoma and the explosion of genetic technologies over the past 20 years, there has been extensive research into the genetic alterations that cause melanocytes to become malignant. More recently, efforts have focused on the genetic changes that drive melanoma metastasis. This review aims to summarize the current knowledge of the genetics of primary cutaneous and ocular melanoma, the genetic changes associated with metastasis in melanoma and other cancer types, and non-genetic factors that may contribute to metastasis.

Entities:  

Keywords:  Cancer; Genetics; Melanoma; Metastasis

Mesh:

Year:  2018        PMID: 29722002     DOI: 10.1007/s10585-018-9893-y

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  177 in total

Review 1.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

2.  A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.

Authors:  Corine Bertolotto; Fabienne Lesueur; Sandy Giuliano; Thomas Strub; Mahaut de Lichy; Karine Bille; Philippe Dessen; Benoit d'Hayer; Hamida Mohamdi; Audrey Remenieras; Eve Maubec; Arnaud de la Fouchardière; Vincent Molinié; Pierre Vabres; Stéphane Dalle; Nicolas Poulalhon; Tanguy Martin-Denavit; Luc Thomas; Pascale Andry-Benzaquen; Nicolas Dupin; Françoise Boitier; Annick Rossi; Jean-Luc Perrot; Bruno Labeille; Caroline Robert; Bernard Escudier; Olivier Caron; Laurence Brugières; Simon Saule; Betty Gardie; Sophie Gad; Stéphane Richard; Jérôme Couturier; Bin Tean Teh; Paola Ghiorzo; Lorenza Pastorino; Susana Puig; Celia Badenas; Hakan Olsson; Christian Ingvar; Etienne Rouleau; Rosette Lidereau; Philippe Bahadoran; Philippe Vielh; Eve Corda; Hélène Blanché; Diana Zelenika; Pilar Galan; François Aubin; Bertrand Bachollet; Céline Becuwe; Pascaline Berthet; Yves Jean Bignon; Valérie Bonadona; Jean-Louis Bonafe; Marie-Noëlle Bonnet-Dupeyron; Fréderic Cambazard; Jacqueline Chevrant-Breton; Isabelle Coupier; Sophie Dalac; Liliane Demange; Michel d'Incan; Catherine Dugast; Laurence Faivre; Lynda Vincent-Fétita; Marion Gauthier-Villars; Brigitte Gilbert; Florent Grange; Jean-Jacques Grob; Philippe Humbert; Nicolas Janin; Pascal Joly; Delphine Kerob; Christine Lasset; Dominique Leroux; Julien Levang; Jean-Marc Limacher; Cristina Livideanu; Michel Longy; Alain Lortholary; Dominique Stoppa-Lyonnet; Sandrine Mansard; Ludovic Mansuy; Karine Marrou; Christine Matéus; Christine Maugard; Nicolas Meyer; Catherine Nogues; Pierre Souteyrand; Laurence Venat-Bouvet; Hélène Zattara; Valérie Chaudru; Gilbert M Lenoir; Mark Lathrop; Irwin Davidson; Marie-Françoise Avril; Florence Demenais; Robert Ballotti; Brigitte Bressac-de Paillerets
Journal:  Nature       Date:  2011-10-19       Impact factor: 49.962

3.  Acral lentiginous melanoma: indolent subtype with long radial growth phase.

Authors:  Jin Yong Kim; Mira Choi; Seong Jin Jo; Hye Sook Min; Kwang Hyun Cho
Journal:  Am J Dermatopathol       Date:  2014-02       Impact factor: 1.533

4.  Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway.

Authors:  Yibin Kang; Wei He; Shaun Tulley; Gaorav P Gupta; Inna Serganova; Chang-Rung Chen; Katia Manova-Todorova; Ronald Blasberg; William L Gerald; Joan Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

5.  Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival.

Authors:  Frank Benedix; Rainer Kube; Frank Meyer; Uwe Schmidt; Ingo Gastinger; Hans Lippert
Journal:  Dis Colon Rectum       Date:  2010-01       Impact factor: 4.585

6.  Analysis of protein tyrosine kinase expression in melanocytic lesions by tissue array.

Authors:  Steven S Shen; Peter S Zhang; Omar Eton; Victor G Prieto
Journal:  J Cutan Pathol       Date:  2003-10       Impact factor: 1.587

7.  Lifetime risks of common cancers among retinoblastoma survivors.

Authors:  Olivia Fletcher; Douglas Easton; Kristin Anderson; Clare Gilham; Marcelle Jay; Julian Peto
Journal:  J Natl Cancer Inst       Date:  2004-03-03       Impact factor: 13.506

8.  Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin.

Authors:  Iñigo Martincorena; Amit Roshan; Moritz Gerstung; Peter Ellis; Peter Van Loo; Stuart McLaren; David C Wedge; Anthony Fullam; Ludmil B Alexandrov; Jose M Tubio; Lucy Stebbings; Andrew Menzies; Sara Widaa; Michael R Stratton; Philip H Jones; Peter J Campbell
Journal:  Science       Date:  2015-05-22       Impact factor: 47.728

9.  A novel AKT3 mutation in melanoma tumours and cell lines.

Authors:  M A Davies; K Stemke-Hale; C Tellez; T L Calderone; W Deng; V G Prieto; A J F Lazar; J E Gershenwald; G B Mills
Journal:  Br J Cancer       Date:  2008-09-23       Impact factor: 7.640

10.  Astrocytes directly influence tumor cell invasion and metastasis in vivo.

Authors:  Ling Wang; Stephanie M Cossette; Kevin R Rarick; Jill Gershan; Michael B Dwinell; David R Harder; Ramani Ramchandran
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

View more
  18 in total

1.  Effect of piceatannol against malignant melanoma in vivo and in vitro.

Authors:  Bo Yu; Wei Liu; Min-Qi Hu; Xiu-Fa Tang; Chun-Jie Li; Lin Que
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-08-01

2.  Novel insights into the pathogenesis and treatment of NRAS mutant melanoma.

Authors:  Jeffrey Zhao; Carlos Galvez; Kathryn Eby Beckermann; Douglas B Johnson; Jeffrey A Sosman
Journal:  Expert Rev Precis Med Drug Dev       Date:  2021-08-11

3.  A novel endoplasmic reticulum stress-related lncRNA prognostic risk model for cutaneous melanoma.

Authors:  An-An Li; Fan Li; Min Lan; Yu Zhang; Dong Xie; Mei-Ying Yan
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-10       Impact factor: 4.322

4.  HIF-1α/VEGF signaling-mediated epithelial-mesenchymal transition and angiogenesis is critically involved in anti-metastasis effect of luteolin in melanoma cells.

Authors:  Chunyu Li; Qi Wang; Shen Shen; Xiaolu Wei; Guoxia Li
Journal:  Phytother Res       Date:  2019-01-17       Impact factor: 5.878

Review 5.  Squaring the circle: circRNAs in melanoma.

Authors:  Nicol Mecozzi; Olga Vera; Florian A Karreth
Journal:  Oncogene       Date:  2021-07-30       Impact factor: 9.867

Review 6.  Intravenously Infused Stem Cells for Cancer Treatment.

Authors:  Alison R Mercer-Smith; Ingrid A Findlay; Hunter N Bomba; Shawn D Hingtgen
Journal:  Stem Cell Rev Rep       Date:  2021-06-17       Impact factor: 5.739

7.  Circ_0013359 facilitates the tumorigenicity of melanoma by regulating miR-136-5p/RAB9A axis.

Authors:  Qi Zhang; Yingfa Feng; Jiangang Feng; Jinming Zhang; Lili Huang
Journal:  Open Life Sci       Date:  2021-05-22       Impact factor: 0.938

8.  Silencing Osteopontin Expression Inhibits Proliferation, Invasion and Induce Altered Protein Expression in Melanoma Cells.

Authors:  Tímea Kiss; Krisztina Jámbor; Viktória Koroknai; István Szász; Helga Bárdos; Attila Mokánszki; Róza Ádány; Margit Balázs
Journal:  Pathol Oncol Res       Date:  2021-03-05       Impact factor: 3.201

9.  Genomic, proteomic, and immunologic associations with a durable complete remission of measurable metastatic melanoma induced by a patient-specific dendritic cell vaccine.

Authors:  Robert O Dillman; Gabriel I Nistor; Aleksandra J Poole
Journal:  Hum Vaccin Immunother       Date:  2019-11-15       Impact factor: 3.452

10.  The Research on the Treatment of Metastatic Skin Cutaneous Melanoma by Huanglian Jiedu Decoction Based on the Analysis of Immune Infiltration Analysis.

Authors:  Ding Li; Shi-Fang Li; Xiao-Yuan Li; Xiao-Wei Sun; Tian-Yue Sun; Guo-Jie Hu
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-21       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.